Related by context. All words. (Click for frequent words.) 56 TMC# C# 56 ATTRACT 55 randomized controlled Phase 55 MOTIVATE 54 LUX Lung 54 ARDIS 53 NO# [002] 53 randomized Phase III 52 RIBBON 52 MOBILITY 52 multicentre 52 ENABLE 52 placebo controlled Phase 52 multicentre randomized 51 RADIANT 51 Phase Ib clinical 51 Phase 1b 51 multicenter Phase 51 phase IIa clinical 51 multicenter randomized placebo controlled 51 PROPEL 50 multicenter randomized double 50 HCV SPRINT 50 BCIRG 50 COMPARE 50 randomized multicenter 50 REVIVE 50 phase IIIb 50 PRECiSE 50 Phase 1a clinical 49 ALLEGRO 49 ACCLAIM 49 PRE SURGE 49 Phase Ib II 49 Phase IIIb 49 STENT 49 EMBRACE 49 VENT 49 SATURN 49 phase IIb 48 dose escalation trial 48 label multicenter Phase 48 multicenter phase 48 PIXEL 48 Phase 1a 48 randomized Phase 48 ILLUMINATE 48 BRITE 48 APPRAISE 48 Phase 1b clinical 48 ASPECT 48 treatment naive genotype 48 STUDY RESULTS 48 Phase 2b study 48 EDICT 48 Phase 2a trial 48 ENACT 48 prospective multicenter 48 PHASE 48 ongoing Phase 1b 48 multicenter randomized controlled 48 Asthma Intervention 48 Phase III randomized 48 STELLAR 47 multicenter 47 phase Ib 47 NSABP 47 Multiple Ascending Dose 47 Initiated Phase 47 Sorafenib HCC Assessment 47 viral kinetic 47 multicenter Phase II 47 ACTIVE 47 multicentre randomized double 47 MONITORING 47 ADVANCE PD 47 phase IIa 47 XL# SAR# 47 Phase 2b 47 RESPOND 47 prospective randomized multicenter 47 Prostate AdenoCarcinoma Treatment 47 Initiate Phase 47 Quinamed 47 CAPRA 47 SUCCEED trial 47 SCOPE OF 47 randomized placebo controlled 47 Randomized Evaluation 47 Phase Ib 47 COMET 47 pharmacokinetic PK 47 Phase 2a clinical 47 Phase 2a 47 BRIM2 47 EXCITE 47 Phase IIb 46 PRELUDE 46 multicenter randomized 46 Phase 46 MEND CABG 46 VISITOR 'S 46 OCCULT 46 TAPAS 46 Truvada tablets 46 TECHNOLOGY FOR 46 REG2 46 Phase 1b dose escalation 46 elotuzumab 46 double blinded randomized 46 Phase #/#a 46 PROACTIVE 46 RE SURGE 46 Phase III multicenter 46 ATTAIN 46 MINDSET 46 phase IIb clinical 46 OBSERVE 46 APTIVUS 46 Randomized Phase 46 Phase III randomized controlled 46 Phase Ib study 46 Resynchronization 46 placebo controlled Phase III 46 PROFILES OF 46 SIGNAL 46 Randomized Phase II 46 DIAGNOSTIC 46 prospective randomized placebo 46 randomized Phase 2b 46 IMPACTS 45 relapsing multiple sclerosis 45 ASSERT 45 ANTI AGING 45 POWER TOOLS 45 SWOG 45 ZACTIMA 45 HORIZONS 45 ONTARGET 45 NAVIGATOR 45 Phase Ib Clinical Trial 45 Phase 2b trial 45 MAGELLAN 45 dose escalation clinical 45 placebo controlled clinical 45 Phase 1b trial 45 IIa clinical 45 neratinib 45 CLOSE TO THE 45 LISTENER 45 TAPESTRY 45 Phase IIb III 45 SPEAR 45 fosbretabulin 45 Phase 2b Study 45 DIAGNOSTICS 45 Phase IIb clinical 45 multicenter randomized clinical 45 NSABP B 45 pivotal Phase 45 WINDOW OF 45 INDIGO 45 STEERING 45 BE READY 45 NCIC CTG 45 BRIM3 45 PARADIGM 45 CALGB 45 dose escalation Phase 45 MERLIN TIMI 45 multicenter randomized Phase 45 CONCERTO 45 Phase IIa 45 BIDDER 'S 45 DSMB recommended 45 Phase 2b clinical 45 DermaVir Patch 45 COMPLIANCE 45 PROACT 45 Pharmacokinetic PK 45 DE STRESS 45 PEG IFN 45 BE SAFE 45 PFO migraine 45 GOUT 45 pharmacokinetic PK study 45 blinded randomized placebo controlled 45 OF CHOICE 44 pharmacokinetics PK 44 oral ridaforolimus 44 registrational 44 Phase 2b kidney transplant 44 POETIC 44 IMPACT IMmunotherapy 44 Testosterone MDTS ® 44 randomized multicentre 44 ACCELERATION 44 ENVIRO 44 Pre RELAX AHF 44 AIR CF2 44 Phase IIIb clinical 44 Phase IIa clinical 44 Phase IIa trial 44 HUMAN CAPITAL 44 ZYBRESTAT fosbretabulin 44 multicenter Phase III 44 TASQ 44 INITIATE 44 randomized discontinuation 44 PILOT PROGRAM 44 TECHNOLOGY TO 44 COGENT 44 ENVISION 44 placebo controlled randomized 44 AIM HIGH 44 dose escalation 44 RIVA D. 44 CAPTURE 44 ACCLAIM II 44 ganetespib 44 BIBW 44 Phase III confirmatory 44 RESOLUTION NO 44 APEX PD 44 label multicenter 44 randomized Phase IIb 44 ASA# 44 MEND CABG II 44 fostamatinib 44 registrational trial 44 LEGACY OF 44 CHAMPION PCI 44 DSMC 44 MONITORS 44 AND SERVE 44 TAUGHT ME 44 AIR CF3 44 HuMax EGFr 44 TAXUS IV 44 PAY PER 44 multicenter clinical 44 REVERSE 44 Study Evaluating 44 Phase 1b Clinical Trial 44 DEPLOY 44 Phase IIb Trial 43 IPASS 43 TRANSMIT 43 PUTIN 'S 43 Adjuvant Colon Cancer 43 TLK# 43 CHASERS 43 tanespimycin 43 Phase Ia 43 Pharmacokinetic Study 43 TG MV 43 vidofludimus 43 RADAR 43 LITES 43 AND BURN 43 YOUR MIND 43 RELATE 43 preclinical efficacy 43 randomized controlled multicenter 43 Pivotal Phase 43 CONDOR 43 phase IIb study 43 randomized multicenter trial 43 designated HVTN 43 multicenter placebo controlled 43 AND SEARCH 43 PROCEED 43 trodusquemine 43 phase Ib clinical 43 Multicenter Phase 43 ALERTS 43 relapsed refractory multiple myeloma 43 DIVERSION 43 WISDOM 43 ACTIVE W 43 FOR CHANGE 43 INSPIRE 43 DYNA 43 WORK EXPERIENCE 43 UPGRADE TO 43 Phase IIB 43 SYNTHESIS 43 AMEND 43 CHECKER 43 alvespimycin 43 PXD# 43 Phase III clinical 43 ATTACH 43 Phase III psoriasis 43 PUBLIC TRANSPORTATION 43 Harry Palmin President 43 Stenting Trial 43 Phase III Pivotal 43 Phase II 43 PACKAGING AND 43 BATTLES ON 43 RECOVER 43 THIS MESSAGE 43 NP2 Enkephalin 43 Domestic Abuse Reporting 43 recurrent glioma 43 Phase III HEAT 43 FORTIS M 43 ACHIEVE 43 CoMeD 43 ALTERNATIVE FUEL 43 IMC #B 43 CIRRUS 43 AVADO 43 Phase III Clinical Trial 43 confirmatory Phase III 43 farletuzumab 43 Liraglutide Effect 43 ROAD SAFETY 43 STEERING COMMITTEE 43 II Clinical Trial 43 BR.# 43 Traficet EN 43 Phase Ib clinical trials 43 SEVEN DAY 43 YOUR E MAIL 43 ADVANCED TECHNOLOGY 43 Bayer HealthCare Onyx Pharmaceuticals 43 YET TO 43 INTERACT 42 label multicenter randomized 42 INFORMATION SYSTEMS 42 TECHNOLOGIES CORPORATION 42 VEST 42 CURRICULUM 42 SUSTAIN 42 TRANS 42 FOR SCHOOLS 42 MASS TRANSIT 42 CRLX# 42 CONSTRUCT 42 trastuzumab emtansine T DM1 42 nab paclitaxel 42 bapineuzumab AAB 42 Randomised 42 Continuous Monitoring 42 IMAGING 42 pivotal Phase III 42 placebo controlled 42 MIND YOUR 42 CONSERV 42 SPATIAL 42 BRAKING 42 Pivotal Trial 42 HEADLIGHTS 42 TMC# [002] 42 SENSOR 42 obatoclax 42 CONTROL ROOM 42 RAPID 42 CAUCASUS 42 PACIFIC NORTHWEST 42 Scopus Affiliation Identifier 42 SMALL PLANE 42 nonrandomized 42 CATIE AD 42 TRAFFIC CONTROL 42 stated Michelle Berrey 42 GOUGING 42 PROTOCOLS 42 COMPONENT 42 SOLAR SYSTEM 42 phase IIb III 42 Phase 1b clinical trials 42 celgosivir 42 MODULAR 42 Advaxis Phase 42 QUESTIONS ANSWERED 42 IMA# 42 COMBO 42 SERVING UP 42 UMTRI 42 Zenvia Phase III 42 REGISTRY 42 ADMIRE HF 42 ARTERY 42 Blind Placebo Controlled Trial 42 Prostate HistoScanning ™ 42 phase 2a 42 WIND TURBINE 42 STRIDE PD 42 CORRIDOR 42 trastuzumab DM1 T DM1 42 MIST II 42 INVENTION 42 BiTE antibody MT# 42 CUP HOPES 42 Syllego system 42 ARTEMIS 42 Exelixis XL# 42 PLEASE BE 42 BRAHMS 42 THIS IS WHAT WE 42 unblinding 42 PIX# [002] 42 WE ALSO 42 controlled multicenter Phase 42 HCV Genotype 42 opioid induced bowel dysfunction 42 ASSESS 42 lintuzumab 42 AIR CF1 42 PROMPT 42 CHAPTERS 42 LUMINATE 42 STATIC 42 TASKi2 42 TRANSIT 42 R roscovitine 42 Phase 2b Trial 42 VALIDATE 42 EVALUATE 42 ascending dose 42 CARING FOR 42 Phase III placebo controlled 42 DECIDE 42 confirmatory Phase 42 ENDEAVOR IV 42 Aplidin R 42 Ispinesib SB # 42 PROGRESSION 42 VALOR trial 42 CONNECTOR 42 ELEVATE 42 rALLy trial 42 IS SHOWING 42 NANOTECH 42 HCD# [002] 42 comparing alemtuzumab 42 blinded randomized 42 NCCTG 42 FUNCTIONING 42 SLEIGH 42 ARCHITECTURAL 42 SCHEME FOR 42 MAPPING 42 axitinib 42 ICAL 42 PRT# 42 THE INITIAL 42 YOUR EMPLOYER 41 SIMPADICO 41 randomized controlled 41 SYMMETRY trial 41 PUBLIC TRANSIT 41 WINDOWS XP 41 masked placebo controlled 41 registrational Phase 41 Aflibercept 41 INTERFACE 41 oral deforolimus 41 PEG Interferon lambda 41 Successfully Completes Phase 41 CO ORDINATOR 41 enroller 41 BUFFER 41 Phase #b/#a 41 Phase 2b randomized 41 RG# [001] 41 GREEN BUILDING 41 blind randomized placebo 41 STEPS 41 volociximab 41 LEARNING TO 41 YOU LEARN 41 placebo controlled dose escalation 41 ROBOTICS 41 ATLAS 41 Phase III VISTA 41 FDA Investigational Device 41 FOLOTYN ® 41 label dose escalation 41 Sibutramine Cardiovascular Outcomes 41 POLS 41 IMPACT DCM 41 tesmilifene 41 OF DESPAIR 41 Phase III 41 LOOKING FOR NEW 41 TUNNEL 41 randomized discontinuation trial 41 ENDORSE 41 EORTC 41 ENERGY SAVING 41 THINK BEFORE 41 TELCYTA 41 PRESCRIPTION DRUG 41 CANCELLATION OF 41 SPIRIT FIRST 41 BACKUPS 41 GLOBAL FUND 41 Dulles Corridor Metrorail 41 PROJECT MANAGEMENT 41 COMMUNITY ARTS 41 initiate Phase IIb 41 OF CHANGE 41 Levacor 41 GETS SOME 41 Dose Escalation 41 DDP# 41 VICTOR E1 41 ANTI ABORTION 41 RECESS 41 TESTING FOR 41 lorcaserin Phase 41 Lovaxin C 41 CRMD# 41 TRADITION OF 41 Phase 2b monotherapy 41 double blinded placebo 41 ZYBRESTAT 41 Human Hookworm Vaccine Initiative 41 SENSORS 41 CARE HF 41 PRIMO 41 THE MEADOWLANDS 41 MATRIX 41 XL# XL# XL# 41 rindopepimut 41 AUTOMATED 41 afatinib 41 Phase 2b Clinical Trial 41 NO ADDITIONAL 41 PLACES TO 41 MADE EASY 41 satraplatin Phase 41 REVIVE Diabetes 41 KRN# 41 SHOP FOR 41 NATIONAL HEALTH 41 TRIAS 41 DOCKET 41 randomized double 41 ZYBRESTAT TM 41 STORK 41 THE DECLINE OF 41 Anthony Tolcher 41 sunitinib malate 41 PROJECTOR 41 Glufosfamide 41 Phase Forward InForm 41 PERISCOPE 41 HALT 41 FUELING 41 LB# [003] 41 PRICE HIKE 41 STRATEGIC ALLIANCE 41 randomized #:#:# 41 imetelstat GRN#L 41 evaluable patients 41 TIRE PRESSURE 41 CATCH THE 41 OPTIONS FOR 41 Phase #b/#a clinical 41 COUNCIL ON 41 Clinical Trial Evaluating 41 EMERGENCIES 41 assessing T DM1 41 OF THE FUTURE 41 VOICES 41 MEDIA INC. 41 GV# [001] 41 Aranesp Therapy 41 RAMPART 41 HEALTHY FOOD 41 multiple ascending dose 41 non nucleoside HCV 41 DURATION 41 IVR IWR 41 liposomal formulation 41 confirmatory clinical 41 ACCESSIBILITY 41 AGER 41 INVENT 41 CRUSADE 41 HCV RESPOND 2 41 Apaziquone 41 fidaxomicin Phase 41 Phase 2b clinical trials 41 DECIPHER 41 BUDGETING 41 IIa trial 41 SCHOOL SUPPLIES 41 Dacogen injection 41 forodesine 41 DATA CENTER 41 CURRENTS 41 ADVOCACY 41 etrials EDC 41 OYSTER BAY 41 STEP 41 controlled multicenter 41 DEVS 41 WAVES ON 41 rALLy clinical trial 41 CERTIFICATION FOR 41 ocrelizumab 41 Confirmatory Phase 41 SAVE LIVES 41 SAFEGUARD 41 CATT 41 GetGoal Phase III 41 unblinded 41 RESOLUTIONS 41 CATALYST 41 tramiprosate Alzhemed TM 41 COMMIT 41 COMPASS 41 Tarceva TM 41 GETTING YOUR 41 ID CARDS 41 velafermin belinostat 40 XCHANGE 40 OF DESTRUCTION 40 ORGANIZING 40 Phase III Psoriasis 40 PLANETS 40 ChronVac C ® 40 PUBLISHER 'S 40 PACCE trial 40 IN YOUR HANDS 40 YOUR TAX DOLLARS 40 PREVENTIVE 40 TEACHERS ARE 40 DIGITS 40 BCX# 40 MONITOR 40 BY CLICKING ON 40 HANDLE 40 YOUR AGE 40 FULL BODY 40 TEAM LEADER 40 LIGHT RAIL 40 TOO GOOD 40 RAINS 40 dose escalation study 40 dosing cohorts 40 Genz # 40 ALLOYS 40 MORE GOALS 40 blinatumomab 40 LIKES TO 40 ACTION NETWORK 40 YOUR BODY 40 pharmacodynamic 40 DYNAMICS 40 ON RECORD 40 MICROPHONE 40 IntelliDrive 40 CINCH 40 WORTHWHILE 40 Tyrima 40 FOOD PROGRAM 40 PF # [001] 40 initiate Phase 2b 40 Plicera 40 STARR 40 CURVES 40 TO TIGHTEN 40 COLLECT 40 UPGRADE FOR 40 dose dose escalation 40 LIKE YOUR 40 SAFENANO 40 Phase IIA 40 SUBMITTED TO 40 DAUGHTERS OF 40 COMMUTE 40 budesonide MMX 40 SIGNAGE 40 CANVAS 40 XL# [003] 40 WATCH YOUR 40 SO LET 'S 40 thorough QT 40 INTEGRAL 40 trastuzumab DM1 40 FOR EDUCATION 40 EMAIL AND 40 enzastaurin 40 cilengitide 40 PUBLIC MEETING ON 40 DESIGN BUILD 40 COALITION FOR 40 dose cohorts 40 GENERATOR 40 REMEDIAL 40 SLICES 40 PASS THIS 40 refractory CLL 40 Investigator Initiated 40 KNAPP 40 SNAPS 40 Phase #/#a clinical 40 Immune Tolerance Network 40 Efficacy Results 40 PUBLIC INPUT 40 TECH HEADS 40 CAPRIE 40 IIa trials 40 SOLO 40 multicentre phase 40 INFINITY 40 Degarelix 40 GEST 40 ROOM TO 40 ENERGY SAVINGS 40 ROUTES 40 PREPARATORY 40 INDUSTRIAL DEVELOPMENT 40 CHECK YOUR 40 SCHOOL BUS 40 FIBRE 40 FIBER 40 BUSINESS TECHNOLOGY 40 DISTRIBUTION AGREEMENT WITH 40 DOG TRAINING 40 CELL TOWER 40 ONE MILE 40 FIRST STEP 40 WAITING FOR THE 40 CR# vcMMAE 40 BioMarck 40 GVAX Pancreas 40 RADAR Respecting Accuracy 40 docetaxel Taxotere R 40 Phase Ib IIa 40 RLY 40 NAB FASTROAD 40 ularitide 40 INSTALLATIONS 40 NCCTG N# 40 pharmacodynamic PD 40 THE VOICE OF 40 PIVOT 40 CANDIDATE 'S 40 TOWED 40 PEG SN# 40 SCANNING 40 Azedra 40 ENQUIRY 40 HARTMANN 40 Annamycin 40 COURT DECISION 40 ENGAGE AF TIMI 40 ASPEX 40 TAXUS ATLAS 40 NOX E# 40 Protease Inhibitor 40 ENABLED 40 AND HUMAN RIGHTS 40 FINGERPRINT 40 YOUR FUTURE 40 CONSULTING GROUP 40 THE ORGANIZATION 40 WRIST 40 PAUL Minn.MN 40 APPLES 40 WE NEED YOUR 40 LOCATOR 40 EOquin TM phase 40 mertansine 40 Pralatrexate 40 EVALUATIONS 40 SMART 40 INTEGRATION 40 FACIT 40 CONSERVE 40 WHITE PAPER 40 SATEL 40 Chevrolet SILVERADO 40 cetrorelix 40 WE HAVE NO 40 ofatumumab 40 TAXUS V 40 PORTION 40 NIH Publication 40 GLOBES 40 FOR TEACHERS 40 LymphoStat B TM 40 AXLE 40 TAKEOFF 40 POUR IN 40 INTEGRATED 40 Phase #/#a trial 40 AWARE 40 Edupoint 40 EXCELLENCE IN 40 GRANT PROGRAM 40 LEARNS 40 DIMENSIONS 40 HELPING PEOPLE 40 treatment naïve genotype 40 ASPERA 40 Phase IIa trials 40 YOUR BRAIN 40 LOVES TO 40 ARRAY OF 40 ADULT LITERACY 40 Randomized phase 40 LOTUS 40 WITH HEART 40 ENHANCEMENT 40 RAPTOR 40 Telatinib 40 EXAMINE 40 VIOLENCE AGAINST WOMEN 39 YOUR GOALS 39 CAMMS# 39 ALIGNMENT 39 SABER 39 Enobia 39 PAROLE BOARD 39 NOT GETTING 39 LCP AtorFen 39 PROTECTS 39 THEY 'VE GOT 39 FUEL CELL 39 TRIP 39 velafermin 39 Capesaris 39 INFO ON 39 HuMax CD4 39 pivotal bioequivalence 39 Phase IIb trial 39 Ceflatonin R 39 PUBLIC SERVICES 39 Phase IIb IIIa 39 CATALOG 39 INNOVATIONS 39 SYMANTEC 39 THIS BLOG 39 STAGE SET FOR 39 Initiates Phase 39 TAG 39 Medidata Designer 39 PEOPLE POWER 39 VACCINE 39 sapacitabine 39 prospective multicenter randomized 39 FACES TOUGH 39 BiovaxID Phase 39 MISTRAL 39 OTHER WAYS 39 M Vax 39 IMPRESS 39 GLOBAL HOLDINGS 39 Interagency Coordinating Committee 39 CADRE 39 ANOTHER MAJOR 39 CHARM 39 laquinimod 39 PI3K/Akt pathway inhibitor 39 DIPLOMA 39 LUNESTA TM 39 QUALITY ASSURANCE 39 VISIONS 39 ARIES 39 ANTI BULLYING 39 PROMOTE 39 elacytarabine 39 Cardio3KG 39 RECYCLE 39 INFORMATICS 39 stage IIIB 39 TASKi3 39 ROLLED 39 BREEDERS CROWN 39 EVERY CHILD 39 NEW TECHNOLOGY 39 PIRE 39 JUST MAKE 39 dose cohort 39 phase IIb trial 39 LibiGel Phase III 39 COURSE FOR 39 HOW MUCH DOES 39 oral treprostinil 39 initiate Phase 39 blind randomized 39 RIVIERA 39 CRISP 39 ACROSS FROM 39 budesonide foam 39 COST EFFECTIVE 39 FACETS 39 PROVENGE ® 39 TEACH 39 Pivotal Study 39 ALARM N 39 PrevOnco ™ 39 FOR HEALTH 39 CONNECTED 39 CONFUSION OVER 39 SETTINGS 39 sequential dose escalation 39 Bezielle 39 SET TO GO 39 ENROLLMENT 39 STOLE MY 39 double blind placebo 39 BIIB# 39 JAUNT 39 TO RECOVERY 39 HUMANA 39 PHYSICAL THERAPY 39 THE SHARPIE FONT 39 SAFE HOME 39 ORGANISE 39 CHOICE AWARD 39 KAPPA 39 NO MORE EXCUSES 39 MANAGEMENT INC. 39 CONNECTS 39 TRYING TO GET 39 LEARNERS 39 KNOWLEDGE IS 39 YOU 'VE WON 39 FORCE PROTECTION 39 HDAC Inhibitor 39 INFORMATION SECURITY 39 MICROCHIP 39 X RAY 39 FASTRACK 39 OPTICS 39 Ozarelix 39 CASPIAN 39 ANNOUNCING THE 39 GRACE 39 LIBERTARIAN 39 SPRINKLER 39 TEMP 39 HEATING AND 39 FEDERAL AID 39 RUNNING INTO 39 Cloretazine R VNP#M 39 NATIVE PLANT 39 YOUR VOICE 39 Relieve Depression 39 deforolimus 39 MAINSTREAM MEDIA 39 SOLUTIONS GROUP 39 clinical trial 39 PALETTE 39 EndoTAG 39 QLT# 39 unique alkylating agent 39 E2 CLO 39 IS EVERYTHING 39 LUCID 39 DIGIT 39 MOVE FORWARD 39 JAK1 39 DOMAINS 39 RhuDex 39 THANKS FOR THE 39 Parkinson Progression Markers 39 JAK inhibitor 39 Completes Patient Enrollment 39 DIGITAL PHOTOGRAPHY 39 OHR/AVR# 39 FINANCIAL MANAGEMENT 39 CHECK OUT THE 39 RECORD1 39 NORDIC 39 single ascending dose 39 WENZEL 39 CALORIE 39 FOUNDERS 39 Sequenced Treatment Alternatives 39 RECOMMEND 39 HOW YOU CAN 39 Phase #b/#a trial 39 Phase Ia Ib 39 Kb Port 39 Feasibility Trial 39 ANYWHERE NEAR 39 Combination REOLYSIN R 39 ON SITE 39 mg/m2 cohort 39 tosedostat 39 GIFT CARD 39 OUR VOICE 39 CONTINUING EDUCATION 39 T DM1 39 PHAST 39 ENTRY FORM 39 GLOW 39 RESTROOM